We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Biopharma

Stay up to date on the topics that matter to you

Sahana Mollah profile page

Senior Manager, CE/Biopharma Applications

Got a Question for Sahana Mollah?

Get in touch using the contact form linked here and we’ll get back to you shortly.

Published Content

Total: 1

Webinar

Advanced Technology To Accelerate Development of Next-Generation Biotherapeutics

On-Demand

Biopharmaceutical companies are transitioning from the development of standard monoclonal antibody therapies to more intricate antibody structures and new genetic medicines. Not only are these molecules more complex, but scientists are also under tremendous pressure to understand molecular liabilities sooner and close the developability gap in a much shorter time frame.

Never miss a story

with the Breaking Science News daily newsletter